Patients with end-stage renal disease undergoing dialysis can develop a secondary carnitine deficiency due to the unrestricted loss of L-carnitine through the dialyser, and L-carnitine has been used for treatment of some patients during long-term haemodialysis
These IV therapies are focused on rehydration, assisting recovery from illness, restoring vitamin and nutrient levels, refreshing cosmetic appearance and reviving your general wellness and wellbeing
Zuurbier CJ, Bertrand L, Beauloye CR, Andreadou I, Ruiz-Meana M, Jespersen NR, Kula-Alwar D, Prag HA, Eric Botker H, Dambrova M, Montessuit C, Kaambre T, Liepinsh E, Brookes PS, Krieg T (2020) Cardiac metabolism as a driver and therapeutic target of myocardial infarction
Trulicity (dulaglutide): Remains a reliable once-weekly diabetes option with cardiovascular risk-reduction language in its FDA labeling
(2024) gkae973
Their combined action has been shown to significantly improve the healing process through enhanced fibroblast and immune cell activity